Gilead Sciences (GILD) Income from Non-Controlling Interests (2009 - 2023)
Gilead Sciences (GILD) reported Income from Non-Controlling Interests of -$12 million for Q4 2023, compared with -$7 million a year earlier.
Powered by 
Analysis
Gilead Sciences (GILD) Income from Non-Controlling Interests (2009 - 2023) Analysis & Trends
For FY2023, Gilead Sciences posted Income from Non-Controlling Interests of -$52 million.
- By year, Income from Non-Controlling Interests came in at -$26 million in FY2022, -$24 million in FY2021, -$34 million in FY2020 and -$22 million in FY2019.
- Five-year quarterly Income from Non-Controlling Interests spans a low of -$26 million in Q1 2023 and a high of -$3 million in Q3 2022.
- Per Business Quant data, the three quarters before Q4 2023 came in at -$8 million (Q3 2023), -$6 million (Q2 2023) and -$26 million (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | - |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | - |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -12.00 Mn |
| Sep 30, 2023 | -8.00 Mn |
| Jun 30, 2023 | -6.00 Mn |
| Mar 31, 2023 | -26.00 Mn |
| Dec 31, 2022 | -7.00 Mn |
| Sep 30, 2022 | -3.00 Mn |
| Jun 30, 2022 | -9.00 Mn |
| Mar 31, 2022 | -7.00 Mn |
| Dec 31, 2021 | -6.00 Mn |
| Sep 30, 2021 | -6.00 Mn |
| Jun 30, 2021 | -5.00 Mn |
| Mar 31, 2021 | -7.00 Mn |
| Dec 31, 2020 | -7.00 Mn |
| Sep 30, 2020 | -7.00 Mn |
| Jun 30, 2020 | -7.00 Mn |
| Mar 31, 2020 | -13.00 Mn |
| Dec 31, 2019 | -7.00 Mn |
| Sep 30, 2019 | -3.00 Mn |
| Jun 30, 2019 | -5.00 Mn |
| Mar 31, 2019 | -7.00 Mn |
API Access
Gilead Sciences Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();